Inventor

BACHOVCHIN WILLIAM W

US62 patents

⚠️ This page may combine multiple inventors who share the name “BACHOVCHIN WILLIAM W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BACHOVCHIN WILLIAM W

TUFTS COLLEGE

Multivalent compounds for crosslinking receptors and uses thereof

Method of regulating glucose metabolism, and reagents related thereto

Method of regulating glucose metabolism, and reagents related thereto

Inhibitors of dipeptidyl-aminopeptidase type IV

Multivalent compounds for crosslinking receptors and uses thereof

Method of regulating glucose metabolism, and reagents related thereto

Stable analogs of peptide and polypeptide therapeutics

Stable analogs of peptide and polypeptide therapeutics

Combination therapies using immuno-dash inhibitors and PGE2 antagonists

FAP-activated proteasome inhibitors for treating solid tumors

FAP-activated proteasome inhibitors for treating solid tumors

Small molecule enhancer for dendritic cell cancer vaccines

Soft protease inhibitors and pro-soft forms thereof

Non-flushing niacin analogues, and methods of use thereof

Inhibitors of fibroblast activation protein alpha

FAP-activated therapeutic agents, and uses related thereto

FAP-activated therapeutic agents, and uses related thereto

FAP-activated therapeutic agents, and uses related thereto

Peptidomimetic inhibitors of post-proline cleaving enzymes

Smart pro-drugs of serine protease inhibitors

Apolipoprotein A1 mimetics and uses thereof

Combination therapies using immuno-dash inhibitors and PGE2 antagonists

Dash inhibitors, and uses related thereto

Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists

FAP-activated proteasome inhibitors for treating solid tumors

Small molecule enhancer for dendritic cell cancer vaccines

Inhibitors of dipeptidyl-aminopeptidase type IV

Non-flushing niacin analogues, and methods of use thereof

Non-flushing niacin analogues, and methods of use thereof

Methods of regulating glucose metabolism, and reagents related thereto

Non-flushing niacin analogues, and methods of use thereof

Combination therapies using immuno-DASH inhibitors and PGE2 antagonists

FAP-activated proteasome inhibitors for treating solid tumors

FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto

BACH BIOSCIENCES LLC

FAP-activated therapeutic agents, and uses related thereto

FAP-activated therapeutic agents, and uses related thereto

Fap-activated therapeutic agents, and uses related thereto

Fap-activated therapeutic agents, and uses related thereto

FAP-activated therapeutic agents, and uses related thereto

FAP-activated therapeutic agents, and uses related thereto

BACHOVCHIN WILLIAM W

FAP-activated proteasome inhibitors for treating solid tumors

Soft protease inhibitors and pro-soft forms thereof

Method of regulating glucose metabolism, and reagents related thereto

Apolipoprotein A1 mimetics and uses thereof

Method of regulating glucose metabolism, and reagents related thereto

NEW ENGLAND MEDICAL CENTER INC

Method of regulating glucose metabolism, and reagents related thereto

Inhibitors of dipeptidyl-aminopeptidase type IV

TRUSTEES OF TUFTS UNIVERSITY

Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions

Boronophenyl analogs of phospholyrosines

DU PONT

Protease inhibitors